As recent studies have demonstrated the EGFR-mediated nuclear localization of PKM2 [8,10,44], we examined whether PSAT1 may alter PKM2 nuclear translocation under EGFR activation in NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.